276 related articles for article (PubMed ID: 2424660)
21. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.
Rosen G; Caparros B; Groshen S; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Huvos AG
Cancer Invest; 1984; 2(3):181-92. PubMed ID: 6203625
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of adjuvant chemotherapy of osteosarcoma with special reference to adriamycin (final report)].
Maeyama I; Furuse K; Yamawaki S; Abe M; Tateishi A; Takeyama S; Furuya K; Fukuma H; Takeuchi S; Shinohara N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3245-51. PubMed ID: 3196042
[TBL] [Abstract][Full Text] [Related]
25. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
26. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
[TBL] [Abstract][Full Text] [Related]
27. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
28. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Meyers PA; Schwartz CL; Krailo M; Kleinerman ES; Betcher D; Bernstein ML; Conrad E; Ferguson W; Gebhardt M; Goorin AM; Harris MB; Healey J; Huvos A; Link M; Montebello J; Nadel H; Nieder M; Sato J; Siegal G; Weiner M; Wells R; Wold L; Womer R; Grier H
J Clin Oncol; 2005 Mar; 23(9):2004-11. PubMed ID: 15774791
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant chemotherapy of osteosarcoma].
Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
[TBL] [Abstract][Full Text] [Related]
31. [Role of adriamycin in the therapy of bone sarcomas].
Benz-Lemoine E
Pathol Biol (Paris); 1987 Jan; 35(1):91-6. PubMed ID: 3550618
[TBL] [Abstract][Full Text] [Related]
32. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
[TBL] [Abstract][Full Text] [Related]
33. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
34. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Winkler K; Bieling P; Bielack S; Delling G; Dose C; Jürgens H; Kotz R; Ritter J; Salzer-Kuntschik M
Clin Orthop Relat Res; 1991 Sep; (270):79-86. PubMed ID: 1715820
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M
Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Miser JS; Krailo M
Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
[No Abstract] [Full Text] [Related]
38. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy preceding surgery in osteogenic sarcoma.
van Oosterom AT; Voûte PA; Taminiau AH; van der Eijken JW
Prog Clin Biol Res; 1985; 201():53-7. PubMed ID: 3867903
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy for osteosarcoma.
Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
